Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-01-04 @ 6:02 PM
Study NCT ID:
NCT00068393
Status:
COMPLETED
Last Update Posted:
2023-07-07
First Post:
2003-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
CDR0000322258
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |